Quest Diagnostics Inc
DGXNYSECIK 1022079HealthcareFiscal year ends Dec 31
Reports and events: 311 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2316:18 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001022079-26-000108 |
| 2026-10-2206:53 ET | 8-K | 8.01 Other events | 0000947871-26-000941 |
| 2026-10-2206:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001022079-26-000097 |
| 2026-10-0616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000947871-26-000922 |
| 2026-07-2316:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001022079-26-000070 |
| 2026-07-2306:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001022079-26-000067 |
| 2026-05-2116:48 ET | 8-K | 5.07 Shareholder vote results | 0001022079-26-000052 |
| 2026-05-0816:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-057938 |
| 2026-05-0116:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-054141 |
| 2026-04-2216:12 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001022079-26-000043 |
| 2026-04-2106:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001022079-26-000040 |
| 2026-04-0616:32 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001140361-26-013356 |
| 2026-03-1216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-26-000244 |
| 2026-02-2616:38 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001022079-26-000015 |
| 2026-02-1006:53 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001022079-26-000005 |
| 2026-01-1216:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-26-000025 |
| 2025-10-2106:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001022079-25-000219 |
| 2025-10-2106:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001022079-25-000218 |
| 2025-07-2316:25 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001022079-25-000175 |
| 2025-07-2206:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001022079-25-000172 |
| 2025-05-2206:28 ET | 8-K | 5.07 Shareholder vote results | 0001022079-25-000154 |
| 2025-04-2316:21 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001022079-25-000120 |
| 2025-04-2206:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001022079-25-000116 |
| 2025-04-0416:37 ET | DEF 14A | Proxy statementPeriod 2025-05-15 | 0000930413-25-001171 |
| 2025-03-1916:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-25-000321 |
| 2025-03-1908:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-25-000317 |
| 2025-02-2016:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001022079-25-000044 |
| 2025-01-3006:47 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001022079-25-000008 |
| 2024-10-2317:24 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001022079-24-000190 |
| 2024-10-2206:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001022079-24-000187 |
| 2024-08-2916:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001022079-24-000173 |
| 2024-08-1916:33 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-090867 |
| 2024-07-2416:44 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001022079-24-000156 |
| 2024-07-2306:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001022079-24-000153 |
| 2024-07-0309:18 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-24-000587 |
| 2024-05-2116:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001022079-24-000138 |
| 2024-05-2109:19 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001022079-24-000133 |
| 2024-04-2416:12 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001022079-24-000099 |
| 2024-04-2306:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001022079-24-000096 |
| 2024-04-0516:33 ET | DEF 14A | Proxy statementPeriod 2024-05-16 | 0000930413-24-001247 |
| 2024-02-2216:18 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001022079-24-000041 |
| 2024-02-0106:49 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001022079-24-000009 |
| 2023-11-0116:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001022079-23-000172 |
| 2023-10-2516:25 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001022079-23-000157 |
| 2023-10-2406:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001022079-23-000154 |
| 2023-09-2916:55 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001022079-23-000147 |
| 2023-07-2716:14 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001022079-23-000136 |
| 2023-07-2606:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001022079-23-000131 |
| 2023-05-1916:33 ET | 8-K | 5.07 Shareholder vote results | 0001022079-23-000104 |
| 2023-04-2816:10 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001022079-23-000093 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 04:31 ET. Listed shows no prices and gives no investment advice.